Leukemia & Lymphoma, Volume 50, Issue 10 (2009)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 50, Issue 10 (2009)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Volume 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs Download issue

Commentary

Article Commentary
Rituximab maintenance therapy in central nervous system lymphoma?
Niels Murawski, Michael Pfreundschuh, Niels Murawski & Michael Pfreundschuh
Pages: 1555-1556
Published online: 08 Oct 2009
CitationforRituximab maintenance therapy in central nervous system lymphoma? | Full Text | References | PDF (127.4 KB)
  • 98 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Charting the path to the cure of chronic lymphocytic leukemia: consolidation strategies currently lead the way
Constantine S. Tam
Pages: 1557-1558
Published online: 08 Oct 2009
CitationforCharting the path to the cure of chronic lymphocytic leukemia: consolidation strategies currently lead the way | Full Text | References | PDF (131.3 KB)
  • 43 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Therapy with the FCR regimen does not overcome chronic lymphocytic leukemia biology: aberrant p53 expression predicts response and survival
Thorsten Zenz & Stephan Stilgenbauer
Pages: 1559-1561
Published online: 08 Oct 2009
First Page PreviewforTherapy with the FCR regimen does not overcome chronic lymphocytic leukemia biology: aberrant p53 expression predicts response and survival | Full Text | References | PDF (342.4 KB)
  • 86 Views
  • 2 CrossRef citations
  • 0Altmetric
Article Commentary
Interferon: Does it still have a role in the 21st century?
Peter McLaughlin & Stefano Sacchi
Pages: 1562-1563
Published online: 08 Oct 2009
CitationforInterferon: Does it still have a role in the 21st century? | Full Text | References | PDF (131.9 KB)
  • 22 Views
  • 1 CrossRef citations
  • 0Altmetric
Article Commentary
Inhibition of stromal cell-derived factor-1/CXCR4 axis for the cure of BCR-ABL positive chronic myeloid leukemia
Giuseppe Saglio & Carmen Fava
Pages: 1564-1565
Published online: 08 Oct 2009
CitationforInhibition of stromal cell-derived factor-1/CXCR4 axis for the cure of BCR-ABL positive chronic myeloid leukemia | Full Text | References | PDF (129.1 KB)
  • 88 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

Review Article
Iron overload, hematopoietic cell transplantation, and graft-versus-host disease
H. Joachim Deeg MD, Emily Spaulding & Howard M. Shulman
Pages: 1566-1572
Published online: 08 Oct 2009
AbstractforIron overload, hematopoietic cell transplantation, and graft-versus-host disease | Full Text | References | PDF (271 KB)
  • 143 Views
  • 26 CrossRef citations
  • 0Altmetric
Article
The role of Toll-like receptors in chronic B cell malignancies
Marta Muzio, Maria T. S. Bertilaccio, Giorgia Simonetti, Michela Frenquelli & Federico Caligaris-Cappio
Pages: 1573-1580
Published online: 08 Oct 2009
AbstractforThe role of Toll-like receptors in chronic B cell malignancies | Full Text | References | PDF (501.9 KB)
  • 365 Views
  • 27 CrossRef citations
  • 0Altmetric

Report

A new co-operative group: the European Myeloma Network Trialist Group
Pages: 1581-1588
Published online: 08 Oct 2009
First Page PreviewforA new co-operative group: the European Myeloma Network Trialist Group | Full Text | PDF (170.1 KB)
  • 68 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901
John C. Byrd, Bercedis L. Peterson, Kanti R. Rai, David Hurd, Raymond Hohl, Michael C. Perry, Jon Gockerman, Sreenivasa Nattam & Richard A. Larson
Pages: 1589-1596
Published online: 08 Oct 2009
AbstractforFludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901 | Full Text | References | PDF (258.2 KB)
  • 142 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy
Ellen J. Schlette, Ellen J. Schlette, Joan Admirand, William Wierda, Lynne Abruzzo, Katherine I. Lin, Susan O'Brien, Susan Lerner, Michael J. Keating & Constantine Tam
Pages: 1597-1605
Published online: 08 Oct 2009
Abstractforp53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy | Full Text | References | PDF (511.8 KB)
  • 169 Views
  • 23 CrossRef citations
  • 0Altmetric
Article
Recombinant interferon-α2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691
S. M. Smith MD, J. Johnson, B. D. Cheson, G. Canellos, G. Petroni, M. Oken, D. Duggan, D. Hurd, J. P. Gockerman, B. Parker, J. Prchal, B. A. Peterson & For the Cancer and Leukemia Group B and Eastern Cooperative Oncology Group
Pages: 1606-1617
Published online: 08 Oct 2009
AbstractforRecombinant interferon-α2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691 | Full Text | References | PDF (453.4 KB)
  • 153 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Clinical outcome in patients with small intestinal non-Hodgkin lymphoma
Shinichi Kako, Kumi Oshima, Miki Sato, Kiriko Terasako, Shinya Okuda, Hideki Nakasone, Rie Yamazaki, Yukie Tanaka, Aki Tanihara, Yutaka Kawamura, Hirokazu Kiyosaki, Takakazu Higuchi, Junji Nishida, Fumio Konishi & Yoshinobu Kanda M.D.
Pages: 1618-1624
Published online: 08 Oct 2009
AbstractforClinical outcome in patients with small intestinal non-Hodgkin lymphoma | Full Text | References | PDF (249.8 KB)
  • 201 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphoma
Stephen D. Smith MD, Stephen D. Smith MD, Brian J. Bolwell, Anjali S. Advani, Steven W. Andresen, Josephine L. Chan, Robert M. Dean, Eric D. Hsi, Matt E. Kalaycio, Brad L. Pohlman, Lisa A. Rybicki & John W. Sweetenham
Pages: 1625-1631
Published online: 08 Oct 2009
AbstractforHigh rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphoma | Full Text | References | PDF (376 KB)
  • 203 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up
Peter H. Wiernik, Fangxin Hong, John H. Glick & John M. Bennett
Pages: 1632-1641
Published online: 08 Oct 2009
AbstractforRadiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up | Full Text | References | PDF (531.6 KB)
  • 60 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
A prospective study of left ventricle function after treatment with rapid-infusion Rituximab in patients with non-Hodgkin lymphoma
Mariano Provencio MD, PhD, Antonio Sanchez, Constanza Maximiano, Blanca Cantos, Miriam Méndez & Félix Bonilla
Pages: 1642-1646
Published online: 08 Oct 2009
AbstractforA prospective study of left ventricle function after treatment with rapid-infusion Rituximab in patients with non-Hodgkin lymphoma | Full Text | References | PDF (148.4 KB)
  • 257 Views
  • 6 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas
Judit M. Jørgensen, Flemming B. Sørensen, Knud Bendix, Johan L. Nielsen, Anette Funder, Marika J. Karkkainen, Tapio Tainola, Annette B. Sørensen, Finn S. Pedersen & Francesco D'Amore
Pages: 1647-1660
Published online: 08 Oct 2009
AbstractforExpression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas | Full Text | References | PDF (2.1 MB)
  • 306 Views
  • 26 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Multicentric plasmocytic Castleman's disease with polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome and coexistent human herpes virus-6 infection – a possible relationship
Ádám Fazakas, Márta Csire, György Berencsi, Ágota Szepesi, András Matolcsy, Lajos Jakab, István karádi & Judit Várkonyi
Pages: 1661-1665
Published online: 08 Oct 2009
AbstractforMulticentric plasmocytic Castleman's disease with polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome and coexistent human herpes virus-6 infection – a possible relationship | Full Text | References | PDF (568.5 KB)
  • 61 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Protein kinase C-beta II expression in diffuse large B-cell lymphoma predicts for inferior outcome of anthracycline-based chemotherapy with and without rituximab
Kritika Chaiwatanatorn, Georgia Stamaratis, Ken Opeskin, Frank Firkin & Harshal Nandurkar
Pages: 1666-1675
Published online: 08 Oct 2009
AbstractforProtein kinase C-beta II expression in diffuse large B-cell lymphoma predicts for inferior outcome of anthracycline-based chemotherapy with and without rituximab | Full Text | References | PDF (662 KB)
  • 73 Views
  • 16 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib
Falk Dillmann, Marlon R. Veldwijk, Stephanie Laufs, Markus Sperandio, Gary Calandra, Frederik Wenz, W. Jens Zeller, Stefan Fruehauf, Falk Dillmann, Marlon R. Veldwijk, Stephanie Laufs, Markus Sperandio, Gary Calandra, Frederik Wenz, W. Jens Zeller & Stefan Fruehauf
Pages: 1676-1686
Published online: 08 Oct 2009
AbstractforPlerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib | Full Text | References | PDF (568.5 KB)
  • 435 Views
  • 50 CrossRef citations
  • 0Altmetric
Article
T-box-expressed-in-T-cells (T-bet) expression by the tumor cells of hairy cell leukemia correlates with interferon-gamma production
Korinna Jöhrens, Korinna Jöhrens, Verena Moos, Thomas Schneider, Ioannis Anagnostopoulos MD, Korinna Jöhrens, Verena Moos, Thomas Schneider & Ioannis Anagnostopoulos MD
Pages: 1687-1692
Published online: 08 Oct 2009
AbstractforT-box-expressed-in-T-cells (T-bet) expression by the tumor cells of hairy cell leukemia correlates with interferon-gamma production | Full Text | References | PDF (300.8 KB)
  • 167 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood
Vladan Rajić, Richard Aplenc, Maruša Debeljak, Veronika Velenšek Prestor, Nataša Karas-Kuželicki, Irena MlinariČ-RašČan & Janez Jazbec
Pages: 1693-1698
Published online: 08 Oct 2009
AbstractforInfluence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood | Full Text | References | PDF (160.9 KB)
  • 320 Views
  • 74 CrossRef citations
  • 0Altmetric
Article
Functional signatures identified in B-cell non-Hodgkin lymphoma profiles
Mohit Aggarwal, Margarita Sánchez-Beato, Mohit Aggarwal, Margarita Sánchez-Beato, Gonzalo Gómez-López, Fátima Al-Shahrour, Nerea Martínez, Antonia Rodríguez, Elena Ruiz-Ballesteros, Francisca I. Camacho, Alberto Pérez-Rosado, Paloma de la Cueva, María J. Artiga, David G. Pisano, Eva Kimby, Joaquín Dopazo, Raquel Villuendas & Miguel A. Piris
Pages: 1699-1708
Published online: 08 Oct 2009
AbstractforFunctional signatures identified in B-cell non-Hodgkin lymphoma profiles | Full Text | References | PDF (1.1 MB)
  • 131 Views
  • 9 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
The simplified mantle cell lymphoma international prognostic index predicts overall survival but not progression-free survival in patients with mantle cell lymphoma treated with fludarabine and cyclophosphamide±rituximab: results of a randomized phase II trial
Heather E. Eve, Jo Gambell, Paul Smith, Wendi Qian & Simon A. J. Rule
Pages: 1709-1711
Published online: 08 Oct 2009
First Page PreviewforThe simplified mantle cell lymphoma international prognostic index predicts overall survival but not progression-free survival in patients with mantle cell lymphoma treated with fludarabine and cyclophosphamide±rituximab: results of a randomized phase II trial | Full Text | References | PDF (199.2 KB)
  • 141 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
Donor-derived hairy cell leukemia
Guillermo J. Ruiz-Argüelles MD, FACP, FRCP (Glasg), Guillermo J. Ruiz-Delgado, Edgar Calderón-Meza, Alejandro Ruiz-Argüelles & Javier Garcés-Eisele
Pages: 1712-1714
Published online: 08 Oct 2009
First Page PreviewforDonor-derived hairy cell leukemia | Full Text | References | PDF (318.9 KB)
  • 36 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement
Mo Xiang Lan, Zhou Xiang Zhen & Wei Hai Ming
Pages: 1715-1717
Published online: 08 Oct 2009
First Page PreviewforCD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement | Full Text | References | PDF (551 KB)
  • 83 Views
  • 9 CrossRef citations
  • 0Altmetric
Letter
Limited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen
Blanca Xicoy, Josep-María Ribera, Pilar Miralles, Juan Berenguer, Rafael Rubio, Beatriz Mahillo, María-Eulalia Valencia, Eugenia Abella, Armando López-Guillermo, Ana Sureda, Mireia Morgades, José-Tomás Navarro, Herminia Esteban, On Behalf of Gesida and Gelcab Groups, Spain & On Behalf of Gesida and Gelcab Groups, Spain
Pages: 1718-1720
Published online: 08 Oct 2009
First Page PreviewforLimited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen | Full Text | References | PDF (335.8 KB)
  • 80 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
Dramatic resolution of respiratory symptoms with imatinib mesylate in patients with chronic myeloid leukemia presenting with lower airway symptoms resembling asthma
Deivasikamani Ramanujam, Feargal McNicholl, Darshayani Furby, Deborah Richardson, Robert J. G. Cuthbert & Mary F. McMullin
Pages: 1721-1722
Published online: 08 Oct 2009
CitationforDramatic resolution of respiratory symptoms with imatinib mesylate in patients with chronic myeloid leukemia presenting with lower airway symptoms resembling asthma | Full Text | References | PDF (126.9 KB)
  • 94 Views
  • 9 CrossRef citations
  • 0Altmetric
Letter
Thymidylate syntase polymorphism relevant for survival in patients with diffuse large B-cell lymphoma?
Mattias Berglund, Göran Roos & Ulf Thunberg
Pages: 1723-1725
Published online: 08 Oct 2009
First Page PreviewforThymidylate syntase polymorphism relevant for survival in patients with diffuse large B-cell lymphoma? | Full Text | References | PDF (228.5 KB)
  • 39 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone – rituximab refractory patients
Michal Sieniawski, Shilpa Bhartia, Jennifer Wilkinson & Stephen John Proctor
Pages: 1726-1730
Published online: 08 Oct 2009
First Page PreviewforIncidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone – rituximab refractory patients | Full Text | References | PDF (561.4 KB)
  • 104 Views
  • 3 CrossRef citations
  • 0Altmetric

Explore articles